Jatinderpal Kalsi

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Ian Jacobs, Usha Menon, Andy Ryan et al. · The Lancet · 2015 · 1.1K citations · Full text

Medicine, Gynecology, Oncology +14

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon, Aleksandra Gentry‐Maharaj, Matthew Burnell et al. · The Lancet · 2021 · 700 citations · Full text

Medicine, Gynecology, Oncology +17

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

Usha Menon, Andy Ryan, Jatinderpal Kalsi et al. · Journal of Clinical Oncology · 2015 · 198 citations · Full text

Medicine, Gynecology, Oncology +17

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

Matthew R. Russell, Ciaren Graham, Alfonsina D’Amato et al. · British Journal of Cancer · 2017 · 120 citations · Full text

Medicine, Gynecology, Oncology +16

Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.

Philip J. Mease, Dennis A. Revicki, Jacek Szechiński et al. · PubMed · 2008 · 94 citations

Medicine, Internal Medicine, Pharmacotherapy +15